Who Owns Citius Pharmaceuticals Stock?
NASDAQ: CTXRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 4.95%
- Held by insiders
- 1.79%
- Institutional holders
- 41
- Institutions 5.0%
- Insiders 1.8%
- Public and other 93.3%
Who owns Citius Pharmaceuticals stock?
Institutional investors own about 5.0% of Citius Pharmaceuticals's shares, spread across 41 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.79% of CTXR.
The largest institutional holders are Geode Capital Management, LLC (0.79%), Vanguard Capital Management LLC (0.72%) and Miller Financial Services LLC (0.47%). Together, the top 10 institutions control 4.1% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their CTXR positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CTXR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 215.54K | 0.79% | -12.4% |
| Vanguard Capital Management LLC | 197.36K | 0.72% | +17.7% |
| Miller Financial Services LLC | 130.00K | 0.47% | +828.6% |
| Citadel Advisors Llc | 124.91K | 0.46% | +100.0% |
| Jane Street Group, LLC | 122.84K | 0.45% | +445.4% |
| Vanguard Fiduciary Trust Co | 77.75K | 0.28% | 0.0% |
| Blackrock Inc. | 69.85K | 0.25% | 0.0% |
| Northern Trust Corporation | 62.74K | 0.23% | +42.7% |
| Xtx Topco Ltd | 59.20K | 0.22% | +178.0% |
| Asset Advisory Group, Inc. | 59.01K | 0.21% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CTXR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 167.74K | 0.61% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 139.15K | 0.51% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 26.36K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 11.65K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Citius Pharmaceuticals?
Geode Capital Management, LLC is the largest institutional shareholder of CTXR, owning 0.79% of shares outstanding (215.54K shares) as of its latest 13F filing.
What percentage of Citius Pharmaceuticals is owned by institutions?
Institutions own about 5.0% of CTXR shares and 5.0% of the public float.
How much of Citius Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 1.79% of CTXR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.